COMPANY PROFILE

Epicore Biosystems

Explore full profile

Developed a proprietary sweat microfluidic sensor to improve health and drive athletic performance

Cambridge, United StatesFounded 2017Health Tech & Medtech

Valuation $100–250M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Epicore Biosystems

Epicore Biosystems, Inc. specializes in developing innovative wearable microfluidic solutions that non-invasively measure sweat biomarkers, skin health, and physiology in real time. The company operates in the health and wellness market, focusing on athletes, clinical trials, and individuals with rare diseases. Its core product, the Gx Sweat Patch, developed in partnership with Gatorade and PepsiCo, is a skin-like wearable patch that pairs with a user-friendly software app to provide real-time, personalized hydration and performance recommendations. Epicore Biosystems generates revenue through the sale of its wearable devices and associated software services, targeting both individual consumers and institutional clients such as sports teams and healthcare providers.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Cambridge, United States
Employees: 42
Open positions: 1
Dealroom signal: 83.0/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Spinout, DT and LS, science-based
Technology: Hardware, Deep Tech, Connected Device
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	May 2025	$6M	$130M	Joyance Partners · Alumni Ventures	↗
SERIES B✓Equity / VC	Feb 2025	$26M	$104M	Steele Foundation for Hope	↗

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Epicore Biosystems website traffic

Latest recorded traffic for Epicore Biosystems is 7.2K monthly website visits, up 89.5% over the last three months. Epicore Biosystems's team grew 16.7% over the past year.

Latest monthly visits7.2K 3-month web change+89.5% 1-year team growth+16.7%

Monthly website visitsDec 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
TRTrianecTPortable pre-hospital stroke diagnosis for ambulance services	Utrecht, Netherlands	Operational	10	$1.5M	$5.9M
VEVenoVisionNon-invasive hemodynamic monitoring for heart failure & at-risk patients in the hospital and at home using ML + thermal imaging	Wilmington, United States	Operational
FCFocused CryoDeveloper of precise cryotherapy devices for minimally invasive tumor treatment	Atlanta, United States	Operational
SEsendanceCustomizable sensor grids for smart wearable devices	Linz, Austria	Operational
XTXoran TechnologiesCompact, low-dose cone beam computed tomography scanners	Ann Arbor, United States	Operational
NENeurauraTransforming women's metabolic and reproductive health with a bioelectronic wearable device	Calgary, Canada	Operational
RERetinaScopeDevelops affordable, handheld retinal imaging devices and an AI-powered online platform to improve early detection and screening of eye diseases	Purmerend, Netherlands	Operational
BPBionic PowerSmart orthosis enhancing mobility for neuromuscular disorders.	Burnaby, Canada	Operational